PRTA Prothena Plc

Prothena Corp PLC is a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.

$26.77  -0.84 (-3.04%)
As of 06/28/2022 15:59:59 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Ireland
IPO date:  12/21/2012
Outstanding shares:  46,806,224
Average volume:  416,854
Market cap:   $1,299,808,840
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B91XRN2
Valuation   (See tab for details)
PE ratio:   19.28
PB ratio:   2.96
PS ratio:   6.45
Return on equity:   15.36%
Net income %:   33.45%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy